Walking Sensation Study

Exclusion Criteria20

• age 65 - 95.
• no severe high blood pressure (systolic \< 180 mmHg and/or diastolic \< 100 mmHg at rest).
• no severe vision impairment: visual acuity ≥ 20/70 as determined by Snellen eye chart.
• slow walking speed: preferred walking speed slower than 1.0 m/s over 10 meter.
• no cognitive impairment: Montreal Cognitive Assessment (MoCA) score ≥ 26 out of 30 possible points.
• foot sensory impairment: Inability to feel the 10 g monofilament at ≥1 of 10 tested sites on either foot is considered a sign of impaired protective sensation. loss.
• diagnosed neurological disorder or injury of the central nervous system, or observation of symptoms consistent with such a condition (Alzheimer's, Parkinson's, stroke, etc.)
• severe arthritis, such as awaiting joint replacement
• current cardiovascular, lung or renal disease; untreated diabetes; terminal illness
• myocardial infarction or major heart surgery in the previous year
• cancer treatment in the past year, except for nonmelanoma skin cancers and cancers having an excellent prognosis (e.g., early stage breast or prostate cancer)
• current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
• currently taking medications that affect the central nervous system, such as benzodiazepines, anti-cholinergic medication, and GABAergic medication, among others
• no severe vision impairment (visual acuity ≥ 20/70 as determined by Snellen eye chart)
• uncontrolled hypertension at rest (systolic \> 180 mmHg and/or diastolic \> 100 mmHg)
• bone fracture or joint replacement in the previous six months
• current enrollment in any other clinical trial
• planning to relocate out of the area during the study period
• non-English\* speaking, due to the likelihood of difficulties following instructions and communicating remotely
• clinical judgment of the investigative team